Risk factors

Arrowhead Pharmaceuticals (ARWR) risk factors

Item 1A of every Arrowhead Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open ARWR in Gloom →
Arrowhead Pharmaceuticals' chart, financials and news, free in your browser.Open ARWR in Gloom →
  • FY2025 10-K risk factors
    64 risks4 new2 dropped22 reworded

    Arrowhead added risks concerning priority review uncertainties, compliance issues for REDEMPLO, debt restrictions from GSK4532990 and daplusiran/tomligisiran financing, and single-source supply chain dependencies.

    Filed Nov 25, 2025
  • FY2024 10-K risk factors
    62 risks

    Clinical stage risks and reliance on unproven drug candidates dominate the filing.

    Filed Nov 26, 2024